Epizyme, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Report date

3/31/2022

Quarter

2022 Q1

Filed

5/16/2022

Shares

182,293

Value ($000)

210

Weight

0.0%

2013 Q4 - 2022 Q1 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q1	5/16/2022	210	0.0%	182,293	3/31/2022
2021 Q4	2/14/2022	253	0.0%	101,289	12/31/2021
2021 Q3	11/15/2021	519	0.0%	101,289	9/30/2021
2021 Q2	8/16/2021	842	0.0%	101,289	6/30/2021
2021 Q1	5/14/2021	698	0.0%	80,119	3/31/2021
2020 Q4	3/1/2021	773	0.0%	71,217	12/31/2020
2020 Q3	11/13/2020	753	0.0%	63,103	9/30/2020
2020 Q2	8/14/2020	1,108	0.0%	68,961	6/30/2020
2020 Q1	5/15/2020	998	0.0%	64,317	3/31/2020
2019 Q4	2/14/2020	1,714	0.0%	69,686	12/31/2019
2014 Q1	5/23/2014	5,688	0.0%	249,865	3/31/2014
2013 Q4	1/31/2014	5,411	0.0%	260,188	12/31/2013